245 related articles for article (PubMed ID: 12845431)
1. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.
Figarola JL; Scott S; Loera S; Tessler C; Chu P; Weiss L; Hardy J; Rahbar S
Diabetologia; 2003 Aug; 46(8):1140-52. PubMed ID: 12845431
[TBL] [Abstract][Full Text] [Related]
2. Novel inhibitors of glycation and AGE formation.
Rahbar S
Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
Figarola JL; Scott S; Loera S; Xi B; Synold T; Rahbar S
Ann N Y Acad Sci; 2005 Jun; 1043():767-76. PubMed ID: 16037304
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.
Satheesan S; Figarola JL; Dabbs T; Rahbar S; Ermel R
Br J Pharmacol; 2014 Jun; 171(12):3103-14. PubMed ID: 24611770
[TBL] [Abstract][Full Text] [Related]
5. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.
Soulis-Liparota T; Cooper ME; Dunlop M; Jerums G
Diabetologia; 1995 Apr; 38(4):387-94. PubMed ID: 7796978
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective effects of a novel inhibitor of advanced glycation.
Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
[TBL] [Abstract][Full Text] [Related]
7. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
Figarola JL; Scott S; Loera S; Xi B; Synold T; Weiss L; Rahbar S
Diabetes Metab Res Rev; 2005; 21(6):533-44. PubMed ID: 15818713
[TBL] [Abstract][Full Text] [Related]
8. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
Degenhardt TP; Alderson NL; Arrington DD; Beattie RJ; Basgen JM; Steffes MW; Thorpe SR; Baynes JW
Kidney Int; 2002 Mar; 61(3):939-50. PubMed ID: 11849448
[TBL] [Abstract][Full Text] [Related]
9. LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat.
Figarola JL; Loera S; Weng Y; Shanmugam N; Natarajan R; Rahbar S
Diabetologia; 2008 May; 51(5):882-91. PubMed ID: 18317729
[TBL] [Abstract][Full Text] [Related]
10. Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat.
Alderson NL; Chachich ME; Frizzell N; Canning P; Metz TO; Januszewski AS; Youssef NN; Stitt AW; Baynes JW; Thorpe SR
Diabetologia; 2004 Aug; 47(8):1385-95. PubMed ID: 15309289
[TBL] [Abstract][Full Text] [Related]
11. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
[TBL] [Abstract][Full Text] [Related]
12. KIOM-79, an Inhibitor of AGEs-Protein Cross-linking, Prevents Progression of Nephropathy in Zucker Diabetic Fatty Rats.
Kim YS; Kim J; Kim CS; Sohn EJ; Lee YM; Jeong IH; Kim H; Jang DS; Kim JS
Evid Based Complement Alternat Med; 2011; 2011():761859. PubMed ID: 19605553
[TBL] [Abstract][Full Text] [Related]
13. Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.
Nyengaard JR; Chang K; Berhorst S; Reiser KM; Williamson JR; Tilton RG
Diabetes; 1997 Jan; 46(1):94-106. PubMed ID: 8971088
[TBL] [Abstract][Full Text] [Related]
14. Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats.
Tanaka Y; Uchino H; Shimizu T; Yoshii H; Niwa M; Ohmura C; Mitsuhashi N; Onuma T; Kawamori R
Eur J Pharmacol; 1999 Jul; 376(1-2):17-22. PubMed ID: 10440084
[TBL] [Abstract][Full Text] [Related]
15. Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathy.
Shcheglova T; Makker S; Tramontano A
J Am Soc Nephrol; 2009 May; 20(5):1012-9. PubMed ID: 19389854
[TBL] [Abstract][Full Text] [Related]
16. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
[TBL] [Abstract][Full Text] [Related]
17. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation.
Nakamura S; Makita Z; Ishikawa S; Yasumura K; Fujii W; Yanagisawa K; Kawata T; Koike T
Diabetes; 1997 May; 46(5):895-9. PubMed ID: 9133561
[TBL] [Abstract][Full Text] [Related]
18. Curcumin, Alone or in Combination with Aminoguanidine, Increases Antioxidant Defenses and Glycation Product Detoxification in Streptozotocin-Diabetic Rats: A Therapeutic Strategy to Mitigate Glycoxidative Stress.
Lima TFO; Costa MC; Figueiredo ID; InĂ¡cio MD; Rodrigues MR; Assis RP; Baviera AM; Brunetti IL
Oxid Med Cell Longev; 2020; 2020():1036360. PubMed ID: 32566072
[TBL] [Abstract][Full Text] [Related]
19. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
Bhatwadekar A; Glenn JV; Figarola JL; Scott S; Gardiner TA; Rahbar S; Stitt AW
Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931
[TBL] [Abstract][Full Text] [Related]
20. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.
Soulis T; Cooper ME; Vranes D; Bucala R; Jerums G
Kidney Int; 1996 Aug; 50(2):627-34. PubMed ID: 8840295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]